RNS Number : 9722H
Alpha Growth PLC
21 November 2018
 

21 November 2018

Alpha Growth plc

("Alpha", or the "Company")

 

SL Investment Management Joint Venture

 

Alpha Growth plc (LSE: ALGW), the financial services specialist in the growing Senior Life Settlement ("SLS") asset class, is pleased to announce that it has signed Heads of Terms with SL Investment Management Limited, ("SLIM"), a UK based full scope FCA regulated alternative investment fund manager, to launch an Open-Ended Fund investing in life settlements (the "Fund").

The Fund is expected to launch in the first quarter of 2019 and has a minimum seed commitment of $10 million conditional on the launch. Alpha and SLIM are co-advisors, with SLIM as the regulated manager. The Fund will be open to global investors. The collaboration of Alpha and SLIM is an alliance of the Executive Teams from both companies, knowing and respecting the abilities of each, to create an offering that gives investors the ability to invest in an SLS fund that provides complete transparency and alignment of interest with its investors. More details of the Fund will follow in due course. Both companies view this collaboration as a start of a long-term  relationship that will be mutually beneficial for each on a wider basis going forward.

Gobind Sahney, Chairman at Alpha Growth, commented:

"We are really pleased to be working with SLIM on this project and look forward to a long and successful collaboration."

Patrick McAdams of SL commented:

"The combination of Alpha and SLIM will be a strong combination unique in the marketplace. We look forward to working with Danny Swick, Gobind Sahney and their team towards the success of the Fund."

 

About SL Investment Management

Since 1990 in longevity assets.

Starting as the specialist in UK traded endowment policies, SLIM entered the US Life Settlement market in 2003, subsequently providing management or investment advice to global institutional investors across multiple portfolios that have acquired more than 2,800 policies with a face value in excess of $2.9 billion.  SLIM has developed expertise in insurance-based investment funds based on UK and US domiciled life policies.  SL is authorised and regulated by the Financial Conduct Authority as an Alternative Investment Fund Manager.  SL is a founding member of the European Life Settlement Association and is dedicated to supporting the Life Settlement Industry to adopt recognisable standards to promote Transparency, a Code of Practice and Self Regulation. SL is also a member of the UK Association of Policy Market Makers founded in 1990. 

The Directors expect to make further announcements in due course and are committed to enhancing shareholder value.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

** ENDS **

For more information, please visit www.algwplc.com or contact the following:

 

Alpha Growth plc

+44 (0) 20 3959 8600

Gobind Sahney, Executive Chairman 

info@algwplc.com



Cassiopeia Services (PR/IR)

+44 (0) 7949 690338

Stefania Barbaglio

Stefania@cassiopeia-ltd.com



Novum Securities Limited (Corporate Broker)

+44 (0) 207 399 9400

Colin Rowbury

crowbury@novumsecurities.com

 

 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

About Alpha Growth plc

Specialist in Longevity Assets

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, Alpha Growth has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Company's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide wholistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
JVEBFLBLVFFBFBX ]]>